Abstract: The invention describes a whole .beta.-glucan drug delivery vehicle that non-specifically enhances the immune response, and is safe for human use. A drug is incorporated into a whole .beta.-glucan microparticle, and the combination is administered to an individual. The .beta.-glucan vehicle allows sustained release of the drug component while simultaneously enhancing the effectiveness of the drug by boosting the individual's endogenous immune response.
Type:
Grant
Filed:
June 15, 1989
Date of Patent:
July 16, 1991
Assignee:
Alpha Beta Technology
Inventors:
Spiros Jamas, Gary R. Ostroff, D. Davidson Easson, Jr.